Casein Kinase 2 Inhibition Sensitizes Medulloblastoma to Temozolomide

Oncogene - United Kingdom
doi 10.1038/s41388-019-0927-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inhibition of Casein Kinase-2 Induces P53-Dependent Cell Cycle Arrest and Sensitizes Glioblastoma Cells to Tumor Necrosis Factor (TNFα)-induced Apoptosis Through SIRT1 Inhibition

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2012English

Quercetin Sensitizes Human Glioblastoma Cells to Temozolomide in Vitro via Inhibition of Hsp27

Acta Pharmacologica Sinica
MedicinePharmacology
2014English

Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide

Cancers
Cancer ResearchOncology
2019English

Momelotinib Sensitizes Glioblastoma Cells to Temozolomide by Enhancement of Autophagy via JAK2/STAT3 Inhibition

Oncology Reports
MedicineCancer ResearchOncology
2019English

Inhibition of Elongation Factor-2 Kinase Augments the Antitumor Activity of Temozolomide Against Glioma

PLoS ONE
Multidisciplinary
2013English

Casein Kinase 2 Inhibition Modulates the DNA Damage Response but Fails to Radiosensitize Malignant Glioma Cells

International Journal of Oncology
Cancer ResearchOncology
2012English

Inhibition of Casein Kinase 2 Protects Oligodendrocytes From Excitotoxicity by Attenuating JNK/p53 Signaling Cascade

Frontiers in Molecular Neuroscience
Molecular NeuroscienceMolecular BiologyCellular
2018English

Casein Kinase II Inhibition Induces Apoptosis in Pancreatic Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2007English

Brca2Deficiency Sensitizes Cells to PARP Inhibition

Cancer Research
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy